Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018416
Filing Date
2019-06-27
Accepted
2019-06-27 17:10:29
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4989
2 EX-24 DOCUMENT attachment1.htm EX-24 4223
  Complete submission text file 0000899243-19-018416.txt   10544
Mailing Address C/O ESPERION THERAPEUTICS, INC. 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address
Ignelzi Troy A. (Reporting) CIK: 0001579829 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 19926240

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902
SIC: 2834 Pharmaceutical Preparations